Skip to main content

Advertisement

Log in

Dent disease in Poland: what we have learned so far?

  • Nephrology - Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Dent disease (DD) is a rare tubulopathy characterized by proximal tubular dysfunction leading to chronic kidney disease (CKD). The aim of the study was to characterize patients with DD in Poland.

Methods

A retrospective analysis of a national cohort with genetically confirmed diagnosis.

Results

Of 24 males, all patients except one carried mutations in the CLCN5 gene; in one patient a mutation in the OCRL gene was disclosed. Molecular diagnosis was delayed 1 year on average (range 0–21 years). The most common features were tubular proteinuria (100%), hypercalciuria (87%), and nephrocalcinosis (56%). CKD (≤stage II) and growth deficiency were found in 45 and 22% of patients, respectively. Over time, a progression of CKD and persistence of growth impairment was noted. Subnephrotic and nephrotic proteinuria (20%) was found in most patients, but tubular proteinuria was assessed in only 67% of patients. In one family steroid-resistant nephrotic syndrome prompted a genetic testing, and reverse phenotyping. Five children (20%) underwent kidney biopsy, and two of them were treated with immunosuppressants. Hydrochlorothiazide and angiotensin-converting enzyme inhibitors were prescribed for a significant proportion of patients (42 and 37.5%, respectively), while supplemental therapy with phosphate, potassium, vitamin D (12.5% each), and alkali (4.2%) was insufficient, when compared to the percentages of patients requiring repletion.

Conclusions

We found CLCN5 mutations in the vast majority of Polish patients with DD. Proteinuria was the most constant finding; however, tubular proteins were not assessed commonly, likely leading to delayed molecular diagnosis and misdiagnosis in some patients. More consideration should be given to optimize the therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Blanchard A, Curis E, Guyon-Roger T et al (2016) Observations of a large Dent disease cohort. Kidney Int 90(2):430–439

    Article  PubMed  Google Scholar 

  2. Hoopes RR, Raja KM, Koich A et al (2004) Evidence for genetic heterogeneity in Dent’s disease. Kidney Int 65:1615–1620

    Article  CAS  PubMed  Google Scholar 

  3. Mansour-Hendili L, Blanchard A, Pottier NL et al (2015) Mutation update of the CLCN5 gene responsible for Dent disease 1. Hum Mutat 36:743–752

    Article  CAS  PubMed  Google Scholar 

  4. Hichri H, Rendu J, Monnier N et al (2011) From Lowe syndrome to Dent disease: correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat 32:379–388

    Article  CAS  PubMed  Google Scholar 

  5. Zaniew M, Bökenkamp A, Kołbuc M et al (2016) Long-term renal outcome in children with OCRL mutations: retrospective analysis of a large international cohort. Nephrol Dial Transplant. doi:10.1093/ndt/gfw350

    PubMed  Google Scholar 

  6. Recker F, Zaniew M , Böckenhauer D et al (2015) Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome. Pediatr Nephrol 30(6):931–943

    Article  PubMed  Google Scholar 

  7. Bökenkamp A, Cheong HI, Hoppe B et al (2009) Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr 155:94–99

    Article  PubMed  Google Scholar 

  8. Sekine T, Komoda F, Miura K et al (2014) Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA: genetic and clinical studies of 86 unrelated patients with low-molecular-weight proteinuria. Nephrol Dial Transplant 29(2):376–384

    Article  CAS  PubMed  Google Scholar 

  9. Akuta N, Lloyd SE, Igarashi T et al (1997) Mutations of CLCN5 in Japanese children with idiopathic low molecular weight proteinuria, hypercalciuria and nephrocalcinosis. Kidney Int 52:911–916

    Article  CAS  PubMed  Google Scholar 

  10. Copelovitch L, Nash MA, Kaplan BS (2007) Hypothesis: Dent disease is an underrecognized cause of focal glomerulosclerosis. Clin J Am Soc Nephrol 2:914–918

    Article  CAS  PubMed  Google Scholar 

  11. Frishberg Y, Dinour D, Belostotsky R et al (2009) Dent’s disease manifesting as focal glomerulosclerosis: is it the tip of the iceberg? Pediatr Nephrol 24:2369–2373

    Article  PubMed  Google Scholar 

  12. Wang X, Anglani F, Beara-Lasic L et al (2016) Glomerular pathology in Dent disease and its association with kidney function. Clin J Am Soc Nephrol 11(12):2168–2176

    Article  PubMed  Google Scholar 

  13. Van Berkel Y, Ludwig M, van Wijk JA, Bökenkamp A (2016) Proteinuria in Dent disease: a review of the literature. Pediatr Nephrol. doi:10.1007/s00467-016-3499-x

    PubMed  PubMed Central  Google Scholar 

  14. Szczepanska M, Zaniew M, Recker F et al (2015) Dent disease in children: diagnostic and therapeutic considerations. Clin Nephrol 84(4):222–230

    Article  CAS  PubMed  Google Scholar 

  15. Utsch B, Bökenkamp A, Benz MR et al (2006) Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am J Kidney Dis 48:942–954

    Article  CAS  PubMed  Google Scholar 

  16. Schwartz GJ, Muñoz A, Schneider MF et al (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637

    Article  PubMed  PubMed Central  Google Scholar 

  17. Levey AS, Coresh J, Greene T et al (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 145:247–254

    Article  CAS  PubMed  Google Scholar 

  18. National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:S1–S266

    Google Scholar 

  19. Heilbron DC, Holliday MA, Al-Dahwi A, Kogan BA (1991) Expressing glomerular filtration rate in children. Pediatr Nephrol 5:5–11

    Article  CAS  PubMed  Google Scholar 

  20. Tanuma A, Sato H, Takeda T et al (2007) Functional characterization of a novel missense CLCN5 mutation causing alterations in proximal tubular endocytic machinery in Dent’s disease. Nephron Physiol 107:87–97

    Article  Google Scholar 

  21. Grand T, Mordasini D, L’Hoste S et al (2009) Novel CLCN5 mutations in patients with Dent’s disease result in altered ion currents or impaired exchanger processing. Kidney Int 76:999–1005

    Article  CAS  PubMed  Google Scholar 

  22. D’Antonio C, Molinski S, Ahmadi S, Huan LJ, Wellhauser L, Bear CE (2013) Conformational defects underlie proteasomal degradation of Dent’s disease-causing mutants of ClC-5. Biochem J 452:391–400

    Article  PubMed  Google Scholar 

  23. Böckenhauer D, Bökenkamp A, Nuutinen M et al (2012) Novel OCRL mutations in patients withDent-2 disease. J Pediatr Genet 1:15–23

    Article  PubMed  PubMed Central  Google Scholar 

  24. Cho HY, Lee BH, Choi HJ, Ha IS, Choi Y, Cheong HI (2008) Renal manifestations of Dent disease and Lowe syndrome. Pediatr Nephrol 23:243–249

    Article  PubMed  Google Scholar 

  25. Edvardsson VO, Goldfarb DS, Lieske JC et al (2013) Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol 28(10):1923–1942

    Article  PubMed  PubMed Central  Google Scholar 

  26. Klootwijk ED, Reichold M, Unwin RJ, Kleta R, Warth R, Bockehauer D (2015) Renal Fanconi syndrome: taking a proximal look at the nephron. Nephol Dial Transplant 30(9):1456–1460

    Article  CAS  Google Scholar 

  27. Ludwig M, Levtchenko E, Bökenkamp A (2014) Clinical utility gene card for: Dent disease (Dent-1 and Dent-2). Eur J Hum Genet 22(11):1338

    Article  CAS  PubMed Central  Google Scholar 

  28. Levtchenko E, Bökenkamp A, Monnens L, Ludwig M. Dent’s disease. In: Sahay M (ed) Diseases of renal parenchyme. InTech—Open Access Publisher, Croatia pp 17–32. ISBN: 978-953-51-0245-8

  29. Ludwig M, Utsch B, Balluch B, Frund S, Kuwertz-Broking E, Bökenkamp A (2006) Hypercalciuria in patients with CLCN5 mutations. Pediatr Nephrol 21:1241–1250

    Article  PubMed  Google Scholar 

  30. Lipska BS, Iatropoulos P, Maranta R et al (2013) Genetic screening in adolescents with steroid-resistant nephrotic syndrome. Kidney Int 84(1):206–213

    Article  CAS  PubMed  Google Scholar 

  31. Raja KA, Schurman S, D’Mello RG et al (2002) Responsiveness of hypercalciuria to thiazide in Dent’s disease. J Am Soc Nephrol 13:2938–2944

    Article  PubMed  Google Scholar 

  32. Blanchard A, Vargas-Poussou R, Peyrard S et al (2008) Effect of hydrochlorothiazide on urinary calcium excretion in Dent disease: an uncontrolled trial. Am J Kidney Dis 52:1084–1095

    Article  CAS  PubMed  Google Scholar 

  33. Gambaro G, Croppi E, Coe F et al (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29(6):715–734

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Alon US (2009) Medical treatment of pediatric urolithiasis. Pediatr Nephrol 24(11):2129–2135

    Article  PubMed  Google Scholar 

  35. Krieger NS, Asplin JR, Frick KK et al (2015) Effect of potassium citrate on calcium phosphate stones in a model of hypercalciuria. J Am Soc Nephrol 26(12):3001–3008

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Cebotaru V, Kaul S, Devuyst O et al (2005) High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent’s disease. Kidney Int 68:642–652

    Article  CAS  PubMed  Google Scholar 

  37. Philips R, Hanchanale VS, Myatt A, Somani B, Nabi G, Biyani CS (2015) Citrate salts for preventing and treating calcium containing kidney stones in adults. Cochrane Database Syst Rev 10:CD010057

    Google Scholar 

Download references

Acknowledgements

We are grateful to the patients and their parents for their invaluable contributions. We thank the Polish Registry of Inherited Tubulopathies (POLtube) and all physicians (listed below), who helped with patient recruitment and contributed with data of their patients. Danuta Zwolińska (Department of Pediatric Nephrology, Wrocław Medical University, Wrocław), Anna Moczulska (Department of Pediatric Nephrology, Kraków), Anna Niemirska, Dariusz Runowski (Department of Nephrology & Kidney Transplantation, The Children’s Memorial Health Institute, Warsaw), Hanna Szymanik-Grzelak (Department of Pediatrics and Nephrology, Medical University of Warsaw, Warsaw), Anna Wasilewska (Department of Pediatrics and Nephrology, Medical University, Białystok) all from Poland, and Franz Schaefer (Division of Paediatric Nephrology, Centre for Pediatric and Adolescent Medicine, Heidelberg, Germany). Part of the research leading to these results (F19 family testing) has received funding from the European Community’s Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 2012-305608 (EURenOmics) and from Bundesministerium für Bildung und Forschung (BMBF) through the e-Rare initiative (PodoNet).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcin Zaniew.

Ethics declarations

Conflict of interest

All other authors have declared no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zaniew, M., Mizerska-Wasiak, M., Załuska-Leśniewska, I. et al. Dent disease in Poland: what we have learned so far?. Int Urol Nephrol 49, 2005–2017 (2017). https://doi.org/10.1007/s11255-017-1676-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-017-1676-x

Keywords

Navigation